{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T07:03:29Z","timestamp":1790751809659,"version":"4.1.0"},"reference-count":46,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,8,3]],"date-time":"2018-08-03T00:00:00Z","timestamp":1533254400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2018.01799","type":"journal-article","created":{"date-parts":[[2018,8,3]],"date-time":"2018-08-03T04:12:37Z","timestamp":1533269557000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":24,"title":["Activating Autophagy Enhanced the Antitumor Effect of Antibody Drug Conjugates Rituximab-Monomethyl Auristatin E"],"prefix":"10.3389","volume":"9","author":[{"given":"Yichen","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuyao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajun","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyun","family":"Luan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyang","family":"Nan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaofei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qicheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youling","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dianwen","family":"Ju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,8,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21387","article-title":"Cancer statistics, 2017","volume":"67","author":"Siegel","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1111\/cas.13239","article-title":"Clinical development of anti-CD19 chimeric antigen receptor T-cell therapy for B-cell non-Hodgkin lymphoma","volume":"108","author":"Makita","year":"2017","journal-title":"Cancer Sci"},{"key":"B3","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1007\/s00262-017-1961-7","article-title":"Novel B7-H4-mediated crosstalk between human non-Hodgkin lymphoma cells and tumor-associated macrophages leads to immune evasion via secretion of IL-6 and IL-10","volume":"66","author":"Che","year":"2017","journal-title":"Cancer Immunol Immunother"},{"key":"B4","doi-asserted-by":"publisher","first-page":"9488","DOI":"10.18632\/oncotarget.3378","article-title":"Translation initiation complex eIF4F is a therapeutic target for dual mTOR kinase inhibitors in non-Hodgkin lymphoma","volume":"6","author":"Demosthenous","year":"2015","journal-title":"Oncotarget"},{"key":"B5","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.drup.2014.11.001","article-title":"Antibody-targeted drugs and drug resistance \u2013 challenges and solutions","volume":"18","author":"Shefet-Carasso","year":"2015","journal-title":"Drug Resist Updat"},{"key":"B6","doi-asserted-by":"publisher","first-page":"5357","DOI":"10.1016\/j.bmcl.2014.10.021","article-title":"Antibody drug conjugates\u2014a new wave of cancer drugs","volume":"24","author":"Bouchard","year":"2014","journal-title":"Bioorg Med Chem Lett"},{"key":"B7","first-page":"1490","article-title":"Approval summary gemtuzumab ozogamicin in relapsed acute myeloid leukemia","volume":"7","author":"Bross","year":"2001","journal-title":"Clin Cancer Res"},{"key":"B8","doi-asserted-by":"publisher","first-page":"3298","DOI":"10.1158\/1078-0432.CCR-14-2035","article-title":"A novel anti-CD22 anthracycline-based antibody-drug conjugate (ADC) that overcomes resistance to auristatin-based ADCs","volume":"21","author":"Yu","year":"2015","journal-title":"Clin Cancer Res"},{"key":"B9","doi-asserted-by":"publisher","first-page":"192","DOI":"10.4161\/auto.26927","article-title":"Autophagy-mediated regulation of macrophages and its applications for cancer","volume":"10","author":"Chen","year":"2014","journal-title":"Autophagy"},{"key":"B10","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1158\/0008-5472.CAN-13-2966","article-title":"The four faces of autophagy: implications for cancer therapy","volume":"74","author":"Gewirtz","year":"2014","journal-title":"Cancer Res"},{"key":"B11","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1172\/JCI73941","article-title":"The role for autophagy in cancer","volume":"125","author":"White","year":"2015","journal-title":"J Clin Invest"},{"key":"B12","doi-asserted-by":"publisher","first-page":"10034","DOI":"10.3390\/ijms150610034","article-title":"Cytotoxic autophagy in cancer therapy","volume":"15","author":"Sharma","year":"2014","journal-title":"Int J Mol Sci"},{"key":"B13","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1111\/j.1745-7254.2008.00732.x","article-title":"Dynamic effects of autophagy on arsenic trioxide-induced death of human leukemia cell line HL60 cells","volume":"29","author":"Yang","year":"2008","journal-title":"Acta Pharmacol Sin"},{"key":"B14","doi-asserted-by":"publisher","first-page":"739","DOI":"10.4161\/auto.19313","article-title":"Dual functions of autophagy in the response of breast tumor cells to radiation: cytoprotective autophagy with radiation alone and cytotoxic autophagy in radiosensitization by vitamin D 3","volume":"8","author":"Bristol","year":"2012","journal-title":"Autophagy"},{"key":"B15","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.jhazmat.2014.01.028","article-title":"Silica nanoparticles induce autophagy and autophagic cell death in HepG2 cells triggered by reactive oxygen species","volume":"270","author":"Yu","year":"2014","journal-title":"J Hazard Mater"},{"key":"B16","doi-asserted-by":"publisher","first-page":"7588","DOI":"10.1016\/j.biomaterials.2014.05.029","article-title":"The role of autophagy in the neurotoxicity of cationic PAMAM dendrimers","volume":"35","author":"Wang","year":"2014","journal-title":"Biomaterials"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.7150\/thno.13181","article-title":"Interplay of oxidative stress and autophagy in PAMAM dendrimers-induced neuronal cell death","volume":"5","author":"Li","year":"2015","journal-title":"Theranostics"},{"key":"B18","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.biomaterials.2015.11.029","article-title":"Inhibition of autophagy overcomes the nanotoxicity elicited by cadmium-based quantum dots","volume":"78","author":"Fan","year":"2016","journal-title":"Biomaterials"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1182\/blood-2003-01-0039","article-title":"cAC10-vcMMAE, an anti-CD30-monomethyl auristatin E conjugate with potent and selective antitumor activity","volume":"102","author":"Francisco","year":"2003","journal-title":"Blood"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1021\/bc050201y","article-title":"Reduction-alkylation strategies for the modification of specific monoclonal antibody disulfides","volume":"16","author":"Sun","year":"2005","journal-title":"Bioconju Chem"},{"key":"B21","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s11912-015-0466-9","article-title":"Development and integration of antibody\u2013drug conjugate in non-Hodgkin lymphoma","volume":"17","author":"Mehta","year":"2015","journal-title":"Curr Oncol Rep"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1158\/1078-0432.CCR-16-0772","article-title":"Phase I study of the anti-CD22 antibody-drug conjugate pinatuzumab vedotin with\/without rituximab in patients with relapsed\/refractory B-cell non-Hodgkin lymphoma","volume":"23","author":"Advani","year":"2017","journal-title":"Clin Cancer Res"},{"key":"B23","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/S1470-2045(15)70128-2","article-title":"Safety and activity of the anti-CD79B antibody\u2013drug conjugate polatuzumab vedotin in relapsed or refractory B-cell non-Hodgkin lymphoma and chronic lymphocytic leukaemia: a phase 1 study","volume":"16","author":"Palanca-Wessels","year":"2015","journal-title":"Lancet Oncol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s13238-016-0323-0","article-title":"Antibody-drug conjugates: recent advances in conjugation and linker chemistries","volume":"9","author":"An","year":"2018","journal-title":"Protein Cell"},{"key":"B25","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/nrd.2016.268","article-title":"Strategies and challenges for the next generation of antibody-drug conjugates","volume":"16","author":"Beck","year":"2017","journal-title":"Nat Rev Drug Discov"},{"key":"B26","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1111\/j.1600-6143.2006.01288.x","article-title":"Rituximab, an anti-cd20 monoclonal antibody: history and mechanism of action","volume":"6","author":"Pescovitz","year":"2006","journal-title":"Am J Transplant"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1602267","DOI":"10.1002\/smll.201602267","article-title":"Sortase A-generated highly potent anti-CD20-MMAE conjugates for efficient elimination of B-lineage lymphomas","volume":"13","author":"Pan","year":"2017","journal-title":"Small"},{"key":"B28","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/BF01741596","article-title":"Adriamycin(hydrazone)-antibody conjugates require internalization and intracellular acid hydrolysis for antitumor activity","volume":"33","author":"Braslawsky","year":"1991","journal-title":"Cancer Immunol Immunother"},{"key":"B29","first-page":"7190","article-title":"Internalizing antibodies are necessary for improved therapeutic efficacy of antibody-targeted liposomal drugs","volume":"62","author":"Sapra","year":"2002","journal-title":"Cancer Res"},{"key":"B30","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1182\/blood.V90.6.2364","article-title":"Conjugation of blocked ricin to an anti-CD19 monoclonal antibody increases antibody-induced cell calcium mobilization and CD19 internalization","volume":"90","author":"Goulet","year":"1997","journal-title":"Blood"},{"key":"B31","doi-asserted-by":"publisher","first-page":"5424","DOI":"10.1074\/jbc.M114.593806","article-title":"Activatory and inhibitory Fcgamma receptors augment rituximab-mediated internalization of CD20 independent of signaling via the cytoplasmic domain","volume":"290","author":"Vaughan","year":"2015","journal-title":"J Bio Chem"},{"key":"B32","doi-asserted-by":"publisher","first-page":"2530","DOI":"10.1182\/blood-2011-01-330357","article-title":"Fc gamma receptor IIb on target B cells promotes rituximab internalization and reduces clinical efficacy","volume":"118","author":"Lim","year":"2011","journal-title":"Blood"},{"key":"B33","doi-asserted-by":"publisher","first-page":"7842","DOI":"10.1158\/1078-0432.CCR-04-1028","article-title":"Efficient elimination of B-lineage lymphomas by anti-CD20-auristatin conjugates","volume":"10","author":"Law","year":"2004","journal-title":"Clin Cancer Res"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1021\/acs.molpharmaceut.5b00116","article-title":"In vitro and in vivo evaluation of cysteine rebridged trastuzumab-MMAE antibody drug conjugates with defined drug-to-antibody ratios","volume":"12","author":"Bryant","year":"2015","journal-title":"Mol Pharm"},{"key":"B35","doi-asserted-by":"publisher","first-page":"7063","DOI":"10.1158\/1078-0432.CCR-04-0789","article-title":"Effects of drug loading on the antitumor activity of a monoclonal antibody drug conjugate","volume":"10","author":"Hamblett","year":"2004","journal-title":"Clin Cancer Res"},{"key":"B36","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1021\/bc400439x","article-title":"Auristatin antibody drug conjugate physical instability and the role of drug payload","volume":"25","author":"Adem","year":"2014","journal-title":"Bioconjug Chem"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1016\/j.drudis.2017.05.011","article-title":"Advances in antibody\u2013drug conjugates: a new era of targeted cancer therapy","volume":"22","author":"Sau","year":"2017","journal-title":"Drug Discov Today"},{"key":"B38","doi-asserted-by":"publisher","first-page":"2688","DOI":"10.1158\/1535-7163.MCT-16-0364","article-title":"Efficient payload delivery by a bispecific antibody-drug conjugate targeting HER2 and CD63","volume":"15","author":"de Goeij","year":"2016","journal-title":"Mol Cancer Ther"},{"key":"B39","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.cell.2011.10.026","article-title":"Autophagy: renovation of cells and tissues","volume":"147","author":"Mizushima","year":"2011","journal-title":"Cell"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1056\/NEJMcibr1114526","article-title":"Tumor-cell death, autophagy, and immunity","volume":"366","author":"Weiner","year":"2012","journal-title":"N Engl J Med"},{"key":"B41","doi-asserted-by":"publisher","first-page":"355","DOI":"10.4161\/15548627.2014.994368","article-title":"Targeting Hedgehog signaling pathway and autophagy overcomes drug resistance of BCR-ABL-positive chronic myeloid leukemia","volume":"11","author":"Zeng","year":"2015","journal-title":"Autophagy"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.4161\/auto.28984","article-title":"A phase I\/II trial of hydroxychloroquine in conjunction with radiation therapy and concurrent and adjuvant temozolomide in patients with newly diagnosed glioblastoma multiforme","volume":"10","author":"Rosenfeld","year":"2014","journal-title":"Autophagy"},{"key":"B43","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1158\/2326-6066.CIR-16-0398","article-title":"Targeting CD47 and autophagy elicited enhanced antitumor effects in non-small cell lung cancer","volume":"5","author":"Zhang","year":"2017","journal-title":"Cancer Immuno Res"},{"key":"B44","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1093\/carcin\/bgy041","article-title":"Disrupting CD47-SIRP\u03b1 axis alone or combined with autophagy depletion for the therapy of glioblastoma","volume":"39","author":"Zhang","year":"2018","journal-title":"Carcinogenesis"},{"key":"B45","doi-asserted-by":"publisher","first-page":"669","DOI":"10.4161\/auto.6083","article-title":"Silencing of Bcl-2 expression by small interfering RNA induces autophagic cell death in MCF-7 breast cancer cells","volume":"4","author":"Akar","year":"2008","journal-title":"Autophagy"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1038\/cdd.2008.51","article-title":"Role of non-canonical beclin 1-independent autophagy in cell death induced by resveratrol in human breast cancer cells","volume":"15","author":"Scarlatti","year":"2008","journal-title":"Cell Death Differ"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.01799\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,21]],"date-time":"2019-10-21T19:40:42Z","timestamp":1571686842000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.01799\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,3]]},"references-count":46,"alternative-id":["10.3389\/fimmu.2018.01799"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2018.01799","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,3]]},"article-number":"1799"}}